Loading...

Repligen Corporation

RGEN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$119.19
$5.13(4.50%)
U.S. Market is Open • 10:18

Repligen Corporation (RGEN) Stock Overview

Explore Repligen Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.6B
P/E Ratio136.61
EPS (TTM)$0.87
ROE0.02%
Fundamental Analysis

AI Price Forecasts

1 Month$142.83
3 Months$108.26
1 Year Target$118.54

RGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Repligen Corporation (RGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.06, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $118.54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 136.61 and a market capitalization of 6.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.10%
5-Day Change
-10.44%
1-Month Change
1.12%
3-Month Change
-27.55%
6-Month Change
-29.30%
Year-to-Date (YTD) Change
-28.23%
1-Year Change
-19.02%
3-Year Change
-30.08%
5-Year Change
-46.56%
All-Time (Max) Change
945.33%

Contact Information

https://www.repligen.com
781 250 0111
Building 1, Waltham, MA, 02453

Company Facts

1,778 Employees
IPO DateApr 29, 1986
CountryUS
Actively Trading

Frequently Asked Questions